Journal of Vascular Nursing
Volume 24, Issue 2 , Pages 56-61 , June 2006

Stem cell use in a patient with an ischemic foot ulcer: A case study

  • Debra Kohlman-Trigoboff, ACNP

      Affiliations

    • Duke University Medical Center, Durham, North Carolina
    • Corresponding Author InformationAddress reprint requests to Debra Kohlman-Trigoboff, ACNP, 403 West 27th Street, Lumberton, NC 28358
  • ,
  • Jeffrey H. Lawson, MD, PhD

      Affiliations

    • Duke University Medical Center, Durham, North Carolina
  • ,
  • Michael P. Murphy, MD

References 

  1. Stem cells: scientific progress and future research directions. National Institutes of Health, June 2001. Available at: www.stemcells.nih.gov/info/scireport/. Accessed October, 2005
  2. Asahara T , Murohara T , Sullivan A , et al.   Isolating putative progenitor endothelial cells for angiogenesis . Science . 1997;275:964–967
  3. Shi Q , Rafii S , Wu MH , et al.   Evidence of circulating bone marrow-derived endothelial cells . Blood . 1998;92:362–367
  4. Hristov M , Wolfgang E , Weber P . Endothelial progenitor cells (mobilization, differentiation and homing) . Atheroscler Thromb Vasc Biol . 2003;23:1185–1189
  5. Takahashi T , Kalka C , Masuda H , et al.   Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization . Nat Med . 1999;5:434–438
  6. Folkman J . Therapeutic angiogenesis in ischemic limbs . Circulation . 1998;97:1108–1110
  7. Kalka C , Masuda H , Takahashi T , et al.   Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization . Proc Natl Acad Sci USA . 2000;97:3422–3427
  8. Shalaby F , Rossant J , Yamaguchi TP , et al.   Failure of blood-island formation and vasculogenesis in flk-1-deficient mice . Nature . 1995;376:62–66
  9. Yasmashita J , Itoh H , Hirashima M , et al.   Flk-1-positive cells derived from embryonic stem cells serve as vascular progenitors . Nature . 2000;408:92–96
  10. Poole TJ , Finkelstein FB , Cox CM . The role of FGF and VGEF in angioblast induction and migration during vascular development . Dev Dyn . 2001;200:1–17
  11. Fam N , Verma S , Kutryk M , Stewart D . Clinician guide to angiogenesis . Circulation . 2003;108:2613–2618
  12. Cooke JP , Losordo DW . Nitric oxide and angiogenesis . Circulation . 2002;105:2133–2135
  13. Simons M , Bonow RO , Chronos NA , et al.   Clinical trials in coronary angiogenesis: issues, problems, consensus. An expert panel summary . Circulation . 2000;102:e73–e86
  14. Weis M , Heeschein C , Glassford AJ , et al.   Statins have biphasic effects on angiogenesis . Circulation . 2002;105:735–741
  15. Walter DH , Rittig K , Bahlmann FH , et al.   Statin therapy accelerates reendotheliazation (a novel effect involving mobilization and incorporation of bone marrow derived endothelial progenitor cells) . Circulation . 2002;105:3017–3024
  16. Fabre JE , Rivard A , Magner M , et al.   Tissue inhibition of angiotensin converting enzyme activity stimulates angiogenesis in vivo . Circulation . 1999;99:3043–3049
  17. Urbich C , Dimmeler S . Endothelial progenitor cells (characterization and role in vascular biology) . Circ Res . 2004;95:343–353
  18. Hill J , Zalos G , Halcox JP , et al.   Circulating endothelial progenitor cells, vascular function, and cardiovascular risk . N Engl J Med . 2003;348:593–600

PII: S1062-0303(06)00030-6

doi: 10.1016/j.jvn.2006.03.004

Journal of Vascular Nursing
Volume 24, Issue 2 , Pages 56-61 , June 2006